CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 202 enrolled
Drug / intervention
Simplified Patient Care Strategy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03253848
NCT03253848N/AActive
CompareCT.gov

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)

ECOG-ACRIN Cancer Research Group·interventional·Posted Aug 18, 2017·Updated May 29, 2026

In Brief

A clinical study evaluating Simplified Patient Care Strategy and Laboratory Biomarker Analysis for Acute Promyelocytic Leukemia With PML-RARA and t(15;17). Active but no longer recruiting, targeting 202 participants across 294 sites in 2 countries.

Detailed Summary

This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Promyelocytic Leukemia With PML-RARA, t(15;17)
CountriesPuerto Rico, United States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/AActive
20182019202020212022202320242025202620272028
First PostedAug 18, 2017
Enrollment StartSep 26, 2017
Primary CompletionApr 27, 2023
Study CompletionDec 31, 2027
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 8.9 years ago

Interventions

Simplified Patient Care Strategyother

Treatment per Acute Promyelocytic Leukemia (APL) Treatment Guidelines plus discussion between doctors and APL expert

Laboratory Biomarker Analysisother

Correlative studies